World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
24683
World Ranking
15632
National Ranking
74

Anders Waage publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anders Waage sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 324 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anders Waage D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anders Waage sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • Member of the Norwegian Academy of Science and Letters Medicine
  • Member of the Norwegian Academy of Science and Letters Medicine

Overview

Anders Waage is affiliated with the Norwegian University of Science and Technology in Norway. Their research mainly spans the fields of medicine and biochemistry, genetics, and molecular biology, with a significant focus on hematology, molecular biology, oncology, genetics, and cancer research.

The core of Waage's research topics revolves around multiple myeloma research and treatments, with additional interests including protein degradation and inhibitors, peptidase inhibition and analysis, cancer treatment and pharmacology, ubiquitin and proteasome pathways, bone health and treatments, and myeloproliferative neoplasms: diagnosis and treatment.

Waage has contributed to numerous publications in various scientific venues. The frequent publication outlets include:

  • Blood
  • Blood Cancer Journal
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • British Journal of Haematology

Some recent significant papers featuring Waage's work are:

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study, published in 2020 in The Lancet Haematology
  • Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project, published in 2022 in the Journal of Clinical Oncology
  • Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group, published in 2021 in The Lancet Oncology
  • Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations, published in 2021 in British Journal of Haematology
  • Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report, published in 2021 in Blood Cancer Journal

Frequent co-authors collaborating with Waage include:

  • Pieter Sonneveld
  • Sonja Zweegman
  • Markus Hansson
  • Fredrik Schjesvold
  • Tobias S. Slørdahl

Waage has been involved in 97 publications related to medicine and 43 in biochemistry, genetics, and molecular biology. Within these, Waage contributed to 52 works in hematology, 36 in molecular biology, 26 in oncology, 7 in genetics, and 5 in cancer research, reflecting a broad and specialized focus on blood cancers and molecular mechanisms underlying these diseases.

Among the research topics Waage covers, the most prominent is multiple myeloma research and treatments, with 88 publications; other notable topics include protein degradation and inhibitors (48 publications), peptidase inhibition and analysis (18), cancer treatment and pharmacology (16), ubiquitin and proteasome pathways (10), bone health and treatments (10), and myeloproliferative neoplasms diagnosis and treatment (6).

Waage is a member of the Norwegian Academy of Science and Letters in the field of medicine.

Best Publications

  • The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome.

    A Waage;P Brandtzaeg;A Halstensen;P Kierulf

  • Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

    A. Waage;A. Halstensen;T. Espevik

  • Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma

    Bhairavi Swaminathan;Guðmar Thorleifsson;Magnus Jöud;Mina Ali

  • Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A. Palumbo;S. V. Rajkumar;M. A. Dimopoulos;P. G. Richardson

  • Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.

    A Waage;A Halstensen;R Shalaby;P Brandtzaeg

  • Inflammatory Response After Open Heart Surgery: Release of Heat-Shock Protein 70 and Signaling Through Toll-Like Receptor-4

    Brit Dybdahl;Alexander Wahba;Egil Lien;Trude H. Flo

  • Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo

    M.R. Shalaby;A. Waage;L. Aarden;T. Espevik

  • Thalidomide for treatment of multiple myeloma: 10 years later

    Antonio Palumbo;Thierry Facon;Pieter Sonneveld;Joan Bladè

  • Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy

    Sissel Linda Opsjøn;Neville C. Wathen;Solveig Tingulstad;Gro Wiedswang

  • Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.

    Anders Waage;Terje Espevik

  • Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials

    Peter M. Fayers;Peter M. Fayers;Antonio Palumbo;Cyrille Hulin;Anders Waage

  • Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

    Michele Cavo;Meral Beksac;Lucia Pantani

  • Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data

    Antonio Palumbo;Sara Bringhen;Shaji K Kumar;Giulia Lupparelli

  • Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

    Therese Standal;Carina Seidel;Øyvind Hjertner;Torben Plesner

  • Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma

    Anders Waage;Peter Gimsing;Peter Fayers;Peter Fayers;Niels Abildgaard

  • Serum syndecan-1: a new independent prognostic marker in multiple myeloma.

    Carina Seidel;Anders Sundan;Martin Hjorth;Ingemar Turesson

  • GLUCOCORTICOIDS INHIBIT THE PRODUCTION OF IL6 FROM MONOCYTES, ENDOTHELIAL CELLS AND FIBROBLASTS

    Anders Waage;Geir Slupphaug;Refaat Shalaby

  • Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

    C Seidel;M Børset;I Turesson;N Abildgaard

  • The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.

    E Terpos;E Terpos;O Sezer;P. I Croucher;R Garcia-Sanz

  • ORIGINAL ARTICLE Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma

    A Palumbo;SV Rajkumar;MA Dimopoulos;PG Richardson

Frequent Co-Authors

Anders Sundan
Anders Sundan Norwegian University of Science and Technology
Pieter Sonneveld
Pieter Sonneveld Erasmus University Rotterdam
Sonja Zweegman
Sonja Zweegman Amsterdam UMC
Terje Espevik
Terje Espevik Norwegian University of Science and Technology
Michele Cavo
Michele Cavo University of Bologna
Roman Hájek
Roman Hájek University of Ostrava
Antonio Palumbo
Antonio Palumbo University of Turin
Mario Boccadoro
Mario Boccadoro University of Turin
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Björn Nilsson
Björn Nilsson Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in Medicine in the USA, there are several alternative pathways and online degrees that can help you enter healthcare roles or advance your career. Many students seek the cheapest dnp programs online to become nurse practitioners or nurse leaders, offering flexibility and affordability compared to traditional programs.

Those interested in pharmacy careers can choose among accredited online pharmacist programs, which prepare graduates for pharmaceutical practice and research. For students leaning toward healthcare administration or data roles, earning an online mhi (Master’s in Health Information) offers a pathway into digital health and medical data management.

Entry-level opportunities are also expanding, with credentialing options like medical billing and coding classes online. These classes are ideal for those seeking quick entry into the healthcare sector without pursuing extended medical study.

With the increasing availability of online healthcare degrees, more students can access flexible, accredited options to match their career goals and personal circumstances.

Best Scientists Citing Anders Waage

Trending Scientists

Recently Published Articles